@iamnorymartinez's HRT safety claims, fact-checked

A TikTok from @iamnorymartinez categorizing gender-affirming hormone therapy (GAHT) options as "safe/recommended" versus "risky/not recommended" has racked up 64,000 views. The video attempts to guide viewers through HRT choices, but mixes legitimate medical concerns with oversimplified categorizations that don't reflect the nuanced reality of hormone therapy.

What does this video actually claim?

Martinez divides HRT options into two clear camps without showing the specific recommendations. The video suggests certain hormones are universally safer than others for gender-affirming care, particularly for transfeminine individuals based on the MTF hashtag.

This black-and-white framing appeals to viewers seeking clear guidance. The Endocrine Society's 2017 clinical practice guidelines actually recommend individualized treatment approaches rather than blanket categorizations.

Without seeing the specific hormones listed in each category, we can't evaluate the accuracy of individual recommendations. The format itself is problematic because it ignores patient-specific factors that determine safety and efficacy.

Do medical guidelines support these distinctions?

Some hormone formulations do carry different risk profiles, but context matters more than Martinez suggests. The WPATH Standards of Care Version 8 emphasizes that treatment selection should consider individual health status, contraindications, and patient preferences rather than following universal hierarchies.

For estrogen therapy, the 2017 Endocrine Society guidelines recommend transdermal preparations over oral forms for patients over 45 or those with cardiovascular risk factors. This reflects real safety differences, with oral estrogen increasing venous thromboembolism risk by 2-6 fold compared to transdermal routes.

Anti-androgens show more complex trade-offs. Spironolactone carries hyperkalemia risks requiring monitoring, while cyproterone acetate (unavailable in the US) has rare but serious hepatotoxicity concerns. These aren't "safe" versus "risky" categories but different monitoring requirements.

What does the research actually show about HRT safety?

The largest study of transgender HRT safety comes from a 2019 BMJ analysis of 2,842 patients followed for median 5.1 years. Overall cardiovascular event rates were low, but varied significantly by hormone type and patient characteristics.

Oral estrogen users had higher rates of venous thromboembolism (5.9 per 1,000 person-years) compared to transdermal users (2.1 per 1,000 person-years). However, absolute risks remained low, and the study found no increased stroke or heart attack rates overall.

The T4T Community Health Project's 2015 survey of 1,849 trans women found that 89% used hormone therapy, with widely varying regimens and monitoring practices. Safety outcomes correlated more strongly with healthcare access and monitoring frequency than specific hormone choices.

Where does this advice fall short?

Martinez's categorical approach ignores the reality that HRT safety depends heavily on individual health status and proper monitoring. A 25-year-old with no health conditions faces different risks than a 50-year-old with diabetes, regardless of which hormones they choose.

The video also doesn't address the safety implications of DIY hormone use, which affects an estimated 24-41% of trans individuals according to various surveys. Without medical supervision, even "safer" hormones can cause serious complications.

Most importantly, the format suggests viewers can make hormone choices based on TikTok videos rather than comprehensive medical evaluation. The Endocrine Society explicitly recommends that HRT initiation and management occur under qualified medical supervision.

What should people actually know about HRT safety?

Hormone therapy safety isn't about picking the "right" hormones from a list but about comprehensive care including proper dosing, monitoring, and risk assessment. Blood tests every 3-6 months during the first year help catch problems early.

The most important safety factor is working with knowledgeable healthcare providers. The UCSF Transgender Care guidelines provide evidence-based protocols that many clinicians follow, balancing efficacy with safety monitoring.

Access remains the biggest barrier to safe HRT. Telemedicine platforms have expanded access to qualified providers who understand transgender health needs and can provide appropriate monitoring and adjustment of therapy based on individual response and risk factors.